Chapters

Transcript

Video

Although nemvaleukin is being investigated in the context of ICI-refractory disease, what might its potential role be in chemotherapy-refractory disease?


Created by

CMEducation Resources | iQ&A Cytokine Immunotherapy Intelligence Zone

Presenter

Ulka Vaishampayan, MBBS

Ulka Vaishampayan, MBBS

Professor of Internal MedicineDirector, Phase I ProgramRogel Cancer CenterUniversity of MichiganAnn Arbor, MI